Literature DB >> 9070257

Inhibition of IL-1-induced IL-6 production by synthetic retinoids.

H Kagechika1, E Kawachi, H Fukasawa, G Saito, N Iwanami, H Umemiya, Y Hashimoto, K Shudo.   

Abstract

The effects of retinoids and retinoid antagonists on IL-6 production in MC3T3-E1 cells were investigated. None of the synthetic retinoids examined stimulated IL-6 production, but all of them strongly inhibited IL-6 production induced by mouse IL-1 alpha. Their inhibitory activities correlated well with their differentiation-inducing activities in HL-60 assay or their binding affinities to nuclear retinoic acid receptors (RARs). Among three retinoid antagonists, two weak antagonists exhibited similar inhibition of mouse IL-1 alpha-induced IL-6 production, whereas a potent retinoid antagonist, 4-(13H-10,11,12,13-tetrahydro-10,10,13,13,15-pentamethyl-dinaph tho[2,3-b] [1,2-e]diazepin-7-yl)benzoic acid (LE540, 14), enhanced IL-6 production under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070257     DOI: 10.1006/bbrc.1997.6087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Beta,beta-carotene decreases peroxisome proliferator receptor gamma activity and reduces lipid storage capacity of adipocytes in a beta,beta-carotene oxygenase 1-dependent manner.

Authors:  Glenn P Lobo; Jaume Amengual; Hua Nan M Li; Marcin Golczak; M Luisa Bonet; Krzysztof Palczewski; Johannes von Lintig
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

3.  Novel potential agents for ulcerative colitis by molecular topology: suppression of IL-6 production in Caco-2 and RAW 264.7 cell lines.

Authors:  María Galvez-Llompart; María Del Carmen Recio Iglesias; Jorge Gálvez; Ramón García-Domenech
Journal:  Mol Divers       Date:  2013-06-23       Impact factor: 2.943

Review 4.  Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer's Disease: a Review of Current Evidence.

Authors:  Niyaz Mohammadzadeh Honarvar; Ahmad Saedisomeolia; Mina Abdolahi; Amir Shayeganrad; Gholamreza Taheri Sangsari; Babak Hassanzadeh Rad; Gerald Muench
Journal:  J Mol Neurosci       Date:  2016-11-18       Impact factor: 3.444

5.  Galactomutarotase and other galactose-related genes are rapidly induced by retinoic acid in human myeloid cells.

Authors:  Tongkun Pai; Qiuyan Chen; Yao Zhang; Reza Zolfaghari; A Catharine Ross
Journal:  Biochemistry       Date:  2007-12-04       Impact factor: 3.162

Review 6.  Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease.

Authors:  Bhaskar C Das; Somsankar Dasgupta; Swapan K Ray
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

Review 7.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

8.  Retinol Levels in Serum and Chronic Skin Lesions of Atopic Dermatitis.

Authors:  Rabindranath Biswas; Goutam Chakraborti; Kheya Mukherjee; Debojyoti Bhattacharjee; Sabyasachi Mallick; Tanmoy Biswas
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494

9.  Decay in Retinoic Acid Signaling in Varied Models of Alzheimer's Disease and In-Vitro Test of Novel Retinoic Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes.

Authors:  Thabat Khatib; David R Chisholm; Andrew Whiting; Bettina Platt; Peter McCaffery
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.